N@N

Carter Gould Maintained (ABBV) at Buy with Increased Target to $175 on, Jan 23rd, 2024

^{Published on 2024-10-28 08:29:23 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $170 to $175 on, Jan 23rd, 2024.

Carter has made no other calls on ABBV in the last 4 months.

There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Rajesh Kumar of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $156 on, Monday, December 18th, 2023
• James Shin of "Deutsche Bank" Initiated at Hold and Held Target at $150 on, Thursday, November 9th, 2023

These are the ratings of the 4 analyists that currently disagree with Carter

---

• Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $180 on, Tuesday, January 2nd, 2024
• Chris Shibutani of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $173 on, Monday, December 11th, 2023
• Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $181 on, Friday, December 1st, 2023
• Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Monday, October 30th, 2023

Contributing Sources

---